The Supreme Court has issued a temporary stay on a lower court ruling in a dispute involving the Food and Drug Administration's approval of the abortion pill mifepristone. The order requires both sides to weigh in by Tuesday and preserves access to the drug for now. The court will take time to more fully consider the issues raised in the court challenge before making a final decision, though it is unclear when they will make a final ruling.
Posts tagged as “FDA”
The Biden administration has asked the Supreme Court to intervene in an emergency dispute over a Texas judge's ruling which prevents pregnant women from obtaining the key abortion drug mifepristone by mail. The Justice Department argues that the ruling countermands the FDA's scientific judgment and would make it more difficult for women to access the drug, particularly in rural areas. The Supreme Court has yet to respond to the motion, which if accepted, would put the lower court ruling on hold and allow women to continue to access the drug by mail.
The Justice Department has announced plans to appeal to the Supreme Court after the Fifth Circuit Court of Appeals reimposed restrictions on mifepristone, commonly known as the abortion pill. Attorney General Merrick Garland said the Justice Department "strongly disagrees" with the court's decision and will be asking the Supreme Court to intervene. The FDA's decision to lift restrictions on mifepristone had been welcomed by abortion rights advocates, and the Supreme Court's decision on the case could have a major impact on the availability of the drug.
The 5th U.S. Circuit Court of Appeals has granted a temporary reprieve to access to the abortion pill mifepristone, allowing the FDA's initial approval of the drug to remain in place but with tighter rules than before. The ruling leaves considerable uncertainty over access to the drug, but it does provide a temporary solution until the full case is heard.
A federal appeals court has partially granted a request to freeze parts of a Texas judge’s order that would have suspended the US Food and Drug Administration’s approval of a medication abortion drug, mifepristone. The court’s order will keep the approval in effect and the drug on the market while an expedited appeal plays out, but under tighter rules that would allow the drug only to be dispensed up to seven weeks, not 10, and not by mail. The decision is expected to be appealed to the Supreme Court.
Key takeaways: Juul Labs Inc. has agreed to pay $462 million to settle claims by six US states and the District of Columbia that it…
A federal judge has issued a ruling to stay the FDA's approval of the abortion drug mifepristone, in response to a lawsuit brought by anti-abortion groups in Texas. The ruling invalidates the FDA's 23-year-old approval of the drug, and the groups have urged the 5th U.S. Circuit Court of Appeals to let the ruling stand. The case is likely to be taken to the Supreme Court, and the outcome could have a significant impact on access to the medication.
Key takeaways: Drug industry leaders have expressed their disapproval of the Texas district court judge’s ruling to invalidate the FDA’s approval of the abortion medication…